SEPSECS antibody (N-Term)
Quick Overview for SEPSECS antibody (N-Term) (ABIN633298)
Target
See all SEPSECS AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- SLA/LP antibody was raised against the N terminal of SLA/LP
-
Characteristics
- Rabbit polyclonal SLA/LP antibody raised against the N terminal of SLA/LP
-
Purification
- Affinity purified
-
Immunogen
- SLA/LP antibody was raised using the N terminal of SLA/LP corresponding to a region with amino acids MDSNNFLGNCGVGEREGRVASALVARRHYRFIHGIGRSGDISAVQPKAAG
-
-
-
-
Application Notes
-
WB: 1 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
SLA/LP Blocking Peptide, (ABIN5616165), is also available for use as a blocking control in assays to test for specificity of this SLA/LP antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SLA/LP antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SEPSECS (Sep (O-phosphoserine) tRNA:Sec (Selenocysteine) tRNA Synthase (SEPSECS))
-
Alternative Name
- SLA/LP
-
Target Type
- Antibody
-
Background
- SLA/LP converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) required for selenoprotein biosynthesis.
-
Molecular Weight
- 49 kDa (MW of target protein)
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-